A promising development in prostate cancer care: can immunotherapy help?
Promising but early immunotherapy developments in localized, high-risk prostate cancer seek to augment standard treatments and improve outcomes.
The Hindu asks for a subscription to read the full story. If you have one, sign in on their site.
0 comments